Free tool
FAERS Monitor: Technetium Tc 99m Mertiatide Kit
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 216820 or its brand name (Technetium Tc 99m Mertiatide Kit, Technetium Tc-99m Mertiatide Kit). Reports on generic versions are filed under their own applications.
Reports
5
Serious
4
80% of reports
Hospitalization
0
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- renal ischaemia3
- drug ineffective1
- radioisotope uptake increased1
- urticaria1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2024 | 4 |
| 2025 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,154 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| radioisotope uptake increased | 1 | 97926.3 | 16541.0 | 23,924 |
| renal ischaemiaSignal | 3 | 23221.5 | 11296.3 | 48,109 |
| urticaria | 1 | 25.1 | 4.4 | 5 |
| drug ineffective | 1 | 3.2 | 0.6 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.